188 related articles for article (PubMed ID: 12186633)
21. Binding of interferon gamma by glycosaminoglycans: a strategy for localization and/or inhibition of its activity.
Fernandez-Botran R; Yan J; Justus DE
Cytokine; 1999 May; 11(5):313-25. PubMed ID: 10328871
[TBL] [Abstract][Full Text] [Related]
22. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils.
Bocharova OV; Breydo L; Salnikov VV; Baskakov IV
Biochemistry; 2005 May; 44(18):6776-87. PubMed ID: 15865423
[TBL] [Abstract][Full Text] [Related]
23. Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK.
Théoleyre S; Kwan Tat S; Vusio P; Blanchard F; Gallagher J; Ricard-Blum S; Fortun Y; Padrines M; Rédini F; Heymann D
Biochem Biophys Res Commun; 2006 Aug; 347(2):460-7. PubMed ID: 16828054
[TBL] [Abstract][Full Text] [Related]
24. Aggregation of prion protein with insertion mutations is proportional to the number of inserts.
Yu S; Yin S; Li C; Wong P; Chang B; Xiao F; Kang SC; Yan H; Xiao G; Tien P; Sy MS
Biochem J; 2007 Apr; 403(2):343-51. PubMed ID: 17187581
[TBL] [Abstract][Full Text] [Related]
25. Glycosaminoglycans provide a binding site for thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathy.
Marinò M; Lisi S; Pinchera A; Marcocci C; Menconi F; Morabito E; Macchia M; Sellari-Franceschini S; McCluskey RT; Chiovato L
Thyroid; 2003 Sep; 13(9):851-9. PubMed ID: 14588099
[TBL] [Abstract][Full Text] [Related]
26. Following the Aggregation of Human Prion Protein on Heparin Functionalized Gold Surface in Real Time.
Zhang T; Pan Y; Kandapal S; Sun X; Xu B
ACS Appl Bio Mater; 2022 Nov; 5(11):5457-5464. PubMed ID: 36228282
[TBL] [Abstract][Full Text] [Related]
27. Identification of a conformational heparin-recognition motif on the peptide hormone secretin: key role for cell surface binding.
Quittot N; Nguyen PT; Nerée AT; Lussier MP; Bourgault S
Biochem J; 2017 Jun; 474(13):2249-2260. PubMed ID: 28536157
[TBL] [Abstract][Full Text] [Related]
28. Heparin inhibits membrane interactions and lipid-induced fibrillation of a prion amyloidogenic determinant.
Bazar E; Sheynis T; Dorosz J; Jelinek R
Chembiochem; 2011 Mar; 12(5):761-7. PubMed ID: 21337481
[TBL] [Abstract][Full Text] [Related]
29. Conformational variation between allelic variants of cell-surface ovine prion protein.
Thackray AM; Yang S; Wong E; Fitzmaurice TJ; Morgan-Warren RJ; Bujdoso R
Biochem J; 2004 Jul; 381(Pt 1):221-9. PubMed ID: 15070397
[TBL] [Abstract][Full Text] [Related]
30. SPR Biosensor Probing the Interactions between TIMP-3 and Heparin/GAGs.
Zhang F; Lee KB; Linhardt RJ
Biosensors (Basel); 2015 Jul; 5(3):500-12. PubMed ID: 26213979
[TBL] [Abstract][Full Text] [Related]
31. The B16F10 cell receptor for a metastasis-promoting site on laminin-1 is a heparan sulfate/chondroitin sulfate-containing proteoglycan.
Engbring JA; Hoffman MP; Karmand AJ; Kleinman HK
Cancer Res; 2002 Jun; 62(12):3549-54. PubMed ID: 12068003
[TBL] [Abstract][Full Text] [Related]
32. Binding of anti-prion agents to glycosaminoglycans: evidence from electronic absorption and circular dichroism spectroscopy.
Zsila F; Gedeon G
Biochem Biophys Res Commun; 2006 Aug; 346(4):1267-74. PubMed ID: 16793017
[TBL] [Abstract][Full Text] [Related]
33. Mapping of possible prion protein self-interaction domains using peptide arrays.
Rigter A; Langeveld JP; Timmers-Parohi D; Jacobs JG; Moonen PL; Bossers A
BMC Biochem; 2007 Apr; 8():6. PubMed ID: 17430579
[TBL] [Abstract][Full Text] [Related]
34. Prion and doppel proteins bind to granule cells of the cerebellum.
Legname G; Nelken P; Guan Z; Kanyo ZF; DeArmond SJ; Prusiner SB
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16285-90. PubMed ID: 12446843
[TBL] [Abstract][Full Text] [Related]
35. The amino-terminal PrP domain is crucial to modulate prion misfolding and aggregation.
Cordeiro Y; Kraineva J; Gomes MP; Lopes MH; Martins VR; Lima LM; Foguel D; Winter R; Silva JL
Biophys J; 2005 Oct; 89(4):2667-76. PubMed ID: 16040743
[TBL] [Abstract][Full Text] [Related]
36. Structural similarities in the CPC clip motif explain peptide-binding promiscuity between glycosaminoglycans and lipopolysaccharides.
Pulido D; Rebollido-Rios R; Valle J; Andreu D; Boix E; Torrent M
J R Soc Interface; 2017 Nov; 14(136):. PubMed ID: 29187635
[TBL] [Abstract][Full Text] [Related]
37. Cationic Peptides and Peptidomimetics Bind Glycosaminoglycans as Potential Sema3A Pathway Inhibitors.
Corredor M; Bonet R; Moure A; Domingo C; Bujons J; Alfonso I; Pérez Y; Messeguer À
Biophys J; 2016 Mar; 110(6):1291-303. PubMed ID: 27028639
[TBL] [Abstract][Full Text] [Related]
38. Prion protein region 23-32 interacts with tubulin and inhibits microtubule assembly.
Osiecka KM; Nieznanska H; Skowronek KJ; Karolczak J; Schneider G; Nieznanski K
Proteins; 2009 Nov; 77(2):279-96. PubMed ID: 19422054
[TBL] [Abstract][Full Text] [Related]
39. Glycosaminoglycans bind to homologous cardiotoxins with different specificity.
Vyas KA; Patel HV; Vyas AA; Wu W
Biochemistry; 1998 Mar; 37(13):4527-34. PubMed ID: 9521773
[TBL] [Abstract][Full Text] [Related]
40. A structural and dynamic model for the interaction of interleukin-8 and glycosaminoglycans: support from isothermal fluorescence titrations.
Krieger E; Geretti E; Brandner B; Goger B; Wells TN; Kungl AJ
Proteins; 2004 Mar; 54(4):768-75. PubMed ID: 14997572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
